Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
about
New perspectives on management of idiopathic pulmonary fibrosisPleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative DiseasesComplement mediators: key regulators of airway tissue remodeling in asthmaHost responses in tissue repair and fibrosisPeripheral blood biomarkers in idiopathic pulmonary fibrosisPulmonary fibrosis: pathogenesis, etiology and regulationSerum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophagesMechanisms of fibrosis: therapeutic translation for fibrotic diseaseDefective efferocytosis by alveolar macrophages in IPF patientsORMDL3 is associated with airway remodeling in asthma via the ERK/MMP-9 pathwayTargeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.Following the path of CCL2 from prostaglandins to periostin in lung fibrosisProtein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis.Macrophages: master regulators of inflammation and fibrosis.The effect of interleukin-13 (IL-13) and interferon-γ (IFN-γ) on expression of surfactant proteins in adult human alveolar type II cells in vitroModulation of lung inflammation by the Epstein-Barr virus protein Zta.New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.Synovial joints: from development to homeostasis.Integrating mechanisms of pulmonary fibrosisSmoking and idiopathic pulmonary fibrosisInterspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targetsSilica promotes the transdifferentiation of rat circulating fibrocytes in vitroAerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice.Pharmacologic therapies for idiopathic pulmonary fibrosis, past and future.A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repairA review of current and novel therapies for idiopathic pulmonary fibrosisTargeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?Th1/M1 conversion to th2/m2 responses in models of inflammation lacking cell death stimulates maturation of monocyte precursors to fibroblastsIL-13 is a therapeutic target in radiation lung injury.Determinants of initiation and progression of idiopathic pulmonary fibrosis.Investigational approaches to therapies for idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosis-an epidemiological and pathological review.New pharmacological strategies for the treatment of pulmonary fibrosis.The evolving pharmacotherapy of pulmonary fibrosis.Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis.Macrophage plasticity and polarization in liver homeostasis and pathology.Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes.The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.Oxidative damage and TGF-β differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease.Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis.
P2860
Q26765586-CE01E5E5-E581-4FC3-9AC5-39BDE66238F4Q26779081-8CF5961E-725D-4762-AA52-4822AD51F8A8Q26796418-561F7D9A-5C97-4AFB-AA36-AAA600ABFEE3Q26852800-78F4C2DA-3611-45E9-98CA-960DD4AF320EQ27000707-E340FD35-6AB6-4652-BA1F-B264015FB48AQ28388425-3DBA190E-D3C7-496D-B00D-165978163BDDQ28748540-F1663B8B-7DC0-4B37-BF4B-CD7336213CC8Q29620307-858F2E1D-59AE-4A70-BFA3-29CFB56418B6Q33649048-E8571D1A-0A81-4A6F-9360-96FA3EA4892DQ33673851-09A4549C-89E5-4312-86D0-A5FA824EDDDDQ33799732-2EF897A8-C1F0-4DA9-B919-615F743AB473Q33799756-525ABD92-FF44-42D1-B44B-28307F507412Q33856238-5C2CF3A0-30E3-4496-9FE4-6CA954CC1D1CQ34076279-63F2E022-AF68-41F8-B2D5-E240E7EE284AQ34353603-FB829F5C-87AE-4698-80A5-665B4203DD37Q34426098-FC455973-6D2B-43D0-A5F1-87C0F0BC6EC3Q34432217-D08CCDC5-CDAD-4FBB-B826-F0F2BBCC4025Q35014047-25B3B62B-7059-4C3B-9118-F46995235DA3Q35106452-99460BE1-AD45-4007-8399-FEEAEACB12CCQ35788811-9CEC1F4F-44C5-4CD4-AC17-567485915218Q35952040-562A6B35-25A9-4126-A8B6-13F9FFCFC513Q36089903-8F7F84CA-D99C-4E8D-9EA6-E08DB09BA924Q36146139-DD00C49F-2C73-4E17-B404-D9CF547849CFQ36264068-986442C0-5A9E-4CFA-94D0-06E1C80DF3CFQ36438280-17286461-49CE-49E6-B6C7-6DFCAE2125ABQ36542274-A3E42C91-96EE-405E-A00C-DEFD869146FAQ37080510-B173C526-A5A1-40D0-A13B-8A72B6D857C4Q37180280-A0F185CB-38F7-49B9-A6F1-D7453938F019Q37526117-83FC0779-B42D-46E8-904B-3F4709E8BCE7Q37594222-3703E889-D6DE-4E97-ADAF-822CFC09F12AQ37742646-DA5DB41F-46F7-4AA1-8019-E833D04E5633Q37788591-D072F457-F383-4FD8-BE4D-66F53E86D040Q37791764-0643F12B-5DCF-4C26-9E60-70945C90E3A2Q38069617-8F23CC5C-28D3-40DD-9E9C-AA1F0B4495E8Q38100470-17A174C4-2989-418B-B759-3932931CFB27Q38151636-84B017EA-1819-46B7-B407-AA053832749DQ38166449-A27041C5-E0A8-4ADD-9154-30AD76BA36FEQ38181073-E1A58A00-FE1F-4FEC-8DE9-221BA346438EQ38413953-43E1D29B-6E1E-430C-B67E-D9473CB0A5A6Q38621453-3BEFD8A7-41E7-4B9D-B19A-903257A34863
P2860
Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
@en
Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
@nl
type
label
Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
@en
Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
@nl
prefLabel
Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
@en
Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
@nl
P2093
P1476
Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2
@en
P2093
Anuk M Das
Brian Whitaker
Cory M Hogaboam
Francis X Farrell
Heena Beck
Holly L Evanoff
Karyn Cochlin
Michelle Bracht
P304
P356
10.1016/J.BIOCEL.2008.02.016
P50
P577
2008-02-23T00:00:00Z